| 3462 |
Nomura Real Estate Master Fund, Inc.
|
Strategy |
|
Announcement Regarding Acquisition of Domestic Real Estate
|
Mar 3, 2026
NEW
|
| 9434 |
SoftBank Group Corp.
|
M&A |
|
Notice Regarding the Start of the Roadshow for the Initial Public Offering of American Depositary Shares by PayPay Corporation in the United States
|
Mar 3, 2026
NEW
|
| 4689 |
LINE Yahoo Corporation
|
M&A |
|
Announcement Regarding the Commencement of Roadshow for the Initial Public Offering of American Depositary Shares in the United States by PayPay Corporation
|
Mar 3, 2026
NEW
|
| 2160 |
GNI Group Corporation
|
M&A |
|
Notice Regarding the Agreement for Full Subsidiarization of Cullgen Inc. by Consolidated Subsidiary Gyre Therapeutics, Inc.
|
Mar 3, 2026
NEW
|
| 6925 |
USHIO INC.
|
M&A |
|
Completion of Share Acquisition of Newly Established Subsidiary of ams-OSRAM AG and Change of the Subsidiary’s Trade Name
|
Mar 3, 2026
NEW
|
| 6758 |
Sony Group Corporation
|
M&A |
|
Notice of Completion of Additional Acquisition of Interest in Peanuts Holdings LLC by Sony Music Entertainment and Sony Pictures Entertainment
|
Mar 3, 2026
NEW
|
| 4506 |
Sumitomo Pharma Co., Ltd.
|
Strategy |
|
Boost 2028: Accelerating a Strong Sumitomo Pharma
|
Mar 2, 2026
NEW
|
| 4506 |
Sumitomo Pharma Co., Ltd.
|
Strategy |
|
Formulation of Boost 2028 ― Accelerating the Strong Sumitomo Pharma ―
|
Mar 2, 2026
NEW
|
| 4502 |
Takeda Pharmaceutical Company Limited
|
Strategy |
|
Acceptance of New Drug Application by the U.S. Food and Drug Administration for rusfertide, a Potential First-in-Class Treatment for Polycythemia Vera, in Collaboration with Protagonist Therapeutics, and Its Designation for Priority Review
|
Mar 2, 2026
NEW
|
| 7205 |
Hino Motors, Ltd.
|
M&A |
|
Notice Regarding the Listing Approval of ARCHION Corporation
|
Mar 2, 2026
NEW
|
| 9201 |
Japan Airlines Co., Ltd.
|
Strategy |
|
Regarding the “JAL Group Management Vision 2035”
|
Mar 2, 2026
NEW
|
| 9166 |
GENDA Corporation
|
M&A |
|
Notice Regarding Acquisition of Fixed Assets of Some Stores of Jokko Co., Ltd. by Our Consolidated Subsidiary and Opening of New Store
|
Mar 2, 2026
NEW
|
| 8953 |
Japan Urban Fund Investment Corporation
|
Strategy |
|
Completion of Domestic Real Estate Trust Beneficiary Rights Transfer [pivo Izumi Chuo & JMF Building Edogawabashi 01] and Notice Regarding Utilization Policy of Capital Gains and Transfer Proceeds
|
Mar 2, 2026
NEW
|
| 6810 |
Maxell Holdings, Ltd.
|
M&A |
|
Notice Regarding Completion of Share Acquisition (Subsidiarization) of New Company Following the Acquisition of Secondary Battery Business from Murata Manufacturing Co., Ltd. and Tohoku Murata Manufacturing Co., Ltd.
|
Mar 2, 2026
|
| 6753 |
Sharp Corporation
|
M&A |
|
Notice Regarding Acquisition of Stock of Synapse Innovation Inc. (Subsidiarization)
|
Mar 2, 2026
|
| 3466 |
Lasalle Logiport REIT
|
Strategy |
|
Notice Regarding Completion of Transfer of Domestic Real Estate Trust Beneficiary Rights
|
Mar 2, 2026
|
| 3226 |
Mitsui Fudosan Accommodation Fund Investment Corporation
|
M&A |
|
Notice on Completion of Domestic Real Estate Acquisition (Campus Terrace Kyudai Gakken Toshi)
|
Mar 2, 2026
|
| 7606 |
United Arrows Ltd.
|
M&A |
|
(Update on Disclosure) Notice Regarding Completion of Transfer of Shares of a Consolidated Subsidiary and Resignation of Director
|
Mar 2, 2026
|
| 3498 |
Kasumigaseki Capital Corporation
|
Strategy |
|
Notice Regarding the Impact of the Situation in the Middle East
|
Mar 2, 2026
|
| 3222 |
United Supermarkets Holdings, Inc.
|
M&A |
|
Notice Regarding Completion of Business Integration with Maxvalu Kanto Co., Ltd., Daiei Kanto Business, and Aeon Market Co., Ltd.
|
Mar 2, 2026
|
